Peptide Cost Calculator — Monthly Protocol Estimates

Most researchers underestimate peptide protocol costs by 40–60% because they calculate vial price alone and ignore reconstitution supplies, shipping, and dosage frequency compounding over weeks. A single tirzepatide protocol at 5mg weekly looks like $45/vial until you realize each vial contains one dose—suddenly that's $180/month before bacteriostatic water, syringes, or alcohol swabs enter the equation. We've guided research teams through this exact budgeting process hundreds of times. The gap between accurate forecasting and budget overruns comes down to understanding dose-per-vial calculations, reconstitution supply chains, and compounding frequency variables most calculators ignore entirely.

How do you calculate monthly peptide protocol costs accurately?

Monthly peptide protocol costs equal (dose per administration × administrations per month × cost per mg) + reconstitution supplies + ancillary materials. A 5mg weekly tirzepatide protocol at $9/mg costs $180 monthly for peptide alone, plus $15–25 for bacteriostatic water, insulin syringes, and alcohol prep pads. Protocols requiring daily dosing like BPC-157 at 250mcg twice daily multiply supply costs by 60 administrations monthly versus 4 for weekly compounds.

Here's the calculation framework researchers miss: peptide cost isn't linear with dose because vial sizes don't scale proportionally. A 10mg vial of semaglutide at $85 delivers four 2.5mg doses. But scaling to 5mg weekly requires two vials monthly ($170), not the $42.50 a naive linear projection would suggest. This article covers dose-per-vial mathematics, hidden ancillary costs that add 15–30% to base peptide price, and compound-specific variables that change monthly budgets by 3–4× depending on protocol structure.

Understanding Dose-Per-Vial Economics

Peptide cost calculator tools fail when they present per-mg pricing without clarifying usable doses per vial. Thymalin at 10mg per vial costs $48. But if your protocol requires 5mg per administration, that vial delivers exactly two doses, making the effective cost $24 per administration, not the $4.80 per mg the price tag suggests. The critical variable is minimum effective dose relative to available vial concentrations.

Lyophilised peptides lose potency once reconstituted. Bacteriostatic water extends viability to 28 days under refrigeration at 2–8°C, but any protocol requiring doses smaller than one-fourth of vial content forces you to either waste peptide or risk using degraded compound past the stability window. A 10mg MK-677 vial used at 1mg daily provides 10 doses across 10 days. Well within the 28-day window. The same vial split into 0.5mg doses stretches to 20 days, still viable. But attempting 0.25mg doses means 40 administrations from a single vial. You'll discard half the reconstituted solution before it's used, effectively doubling your per-dose cost.

Concentration mismatches between available vial sizes and required doses are the single largest hidden cost multiplier in peptide protocols. Calculate doses per vial before calculating monthly spend. A compound that looks affordable at $6/mg becomes prohibitive when vial geometry forces you to purchase twice the peptide you can use within the stability window.

Monthly Protocol Budget Variables

Monthly peptide costs scale with three compounding variables: dosage frequency, titration schedules, and reconstitution supply consumption. A weekly administration protocol like Cerebrolysin at 5mL per dose requires four vials monthly if each vial contains 5mL. Daily protocols like Dihexa at 5mg daily consume 150mg monthly. If available in 50mg vials at $78 each, that's three vials and $234 monthly before supplies.

Titration schedules introduce cost nonlinearity because early weeks use lower doses while later weeks plateau at maintenance levels. A semaglutide protocol starting at 0.25mg weekly and escalating to 1mg weekly over 16 weeks doesn't cost a flat monthly rate. Weeks 1–4 cost $22.50 monthly (0.25mg × 4 weeks × $22.50/mg calculated from typical $45 per 2mg vial pricing), while weeks 13–16 cost $90 monthly at the 1mg maintenance dose. Budgeting tools that average across the titration period underestimate early affordability and overestimate cumulative 4-month spend.

Reconstitution supplies add 15–30% to base peptide cost depending on protocol frequency. Bacteriostatic water at $12 per 30mL bottle provides enough diluent for 10–15 reconstitutions assuming 2–3mL per vial. Insulin syringes cost $0.15–0.25 each. A daily protocol burns through 30 syringes monthly ($4.50–7.50), while weekly protocols use four ($0.60–1.00). Alcohol prep pads at $0.05 each seem negligible until daily administration makes them a $1.50 monthly line item. Our team has found that researchers who calculate peptide cost alone consistently undershoot actual spend by $18–35 monthly once supplies compound across weeks.

Peptide Cost Calculator: Monthly Estimate Comparison

What If: Peptide Cost Calculator Scenarios

What If My Protocol Requires a Dose That Doesn't Match Available Vial Sizes?

Purchase the next-largest vial size and reconstitute with enough bacteriostatic water to create the concentration you need. If you require 3mg per dose but vials come in 5mg or 10mg sizes, buy the 5mg vial and reconstitute with 1.67mL bacteriostatic water. This creates a 3mg/mL concentration, allowing you to draw exactly 1mL per administration. The unused 2mg from the vial can support a second dose at 2mg if protocol flexibility allows, or be discarded at day 28 if not used within the stability window.

What If I Want to Reduce Monthly Costs Without Changing the Peptide or Dose?

Switch to less frequent administration if pharmacokinetics permit. Growth hormone secretagogues like CJC-1295 have half-lives allowing 3–5× weekly dosing instead of daily. This cuts monthly syringe and alcohol prep costs by 50–70% while maintaining therapeutic effect through pulsatile release patterns. For compounds requiring daily administration due to short half-lives, cost reduction requires either lowering dose (if clinically viable) or switching to a more affordable compound with similar mechanism.

What If the Peptide I Need Costs More Than My Monthly Budget Allows?

Prioritize compounds with longer half-lives and lower required doses. SLU-PP-332 at 10mg weekly costs less monthly than Tesofensine at 500mcg daily despite similar per-mg pricing because weekly administration reduces both peptide consumption and supply costs. Alternatively, implement intermittent dosing schedules where the compound's mechanism allows. Five days on, two days off reduces monthly dose requirements by 28% without fully interrupting receptor engagement in compounds where continuous saturation isn't required for effect.

The Unvarnished Truth About Peptide Budgeting

Here's the honest answer: most peptide cost calculators are built to sell you peptides, not help you budget accurately. They show per-mg pricing in large fonts and bury the dose-per-vial math that determines what you'll actually spend. A compound advertised at $8/mg sounds affordable until you realize your required 4mg weekly dose comes in 5mg vials. Suddenly you're buying five vials monthly to get 20mg total dose, spending $200 when the per-mg math suggested $160. The vial is the atomic unit of cost, not the milligram. If your protocol doesn't align with available vial sizes, you pay for the full vial whether you use all of it or not.

Reconstitution waste is the second hidden cost no calculator acknowledges. Bacteriostatic water once opened degrades. The benzyl alcohol preservative that inhibits bacterial growth doesn't prevent oxidative degradation of the peptide itself once dissolved. That 28-day stability window isn't conservative medical advice; it's the point at which measurable potency loss begins for most lyophilised compounds stored at 2–8°C. Researchers who stretch reconstituted peptides to 35–40 days because 'it still looks clear' are injecting degraded protein fragments with reduced receptor affinity. You're not saving money by using old reconstitution. You're nullifying the dose while still consuming supplies.

The cost floor for any peptide protocol is $65–80 monthly even for the most affordable compounds because reconstitution supplies, shipping, and minimum order quantities create overhead that doesn't scale below a certain threshold. Researchers chasing $40/month protocols are either buying from unverified sources without third-party testing, using dosages below therapeutic thresholds, or miscalculating their actual monthly consumption. Budget accordingly. Peptide research has a cost floor, and undercutting it compromises either purity or efficacy.

Calculating Cost Per Administration

Monthly budgets mean nothing without per-administration cost calculations because protocols change mid-cycle as you titrate up or adjust based on response. The formula: (vial cost ÷ vial mg content) × mg per dose = cost per administration. A $95 Mazdutide vial at 10mg used in 2.5mg doses costs $23.75 per administration. Four administrations monthly totals $95. The monthly cost equals the vial cost because the protocol consumes exactly one vial per month at standard weekly dosing.

This breaks down when protocols don't align cleanly with vial sizes. KPV at 5mg per vial costs $42. But if your protocol requires 2mg per dose, you get 2.5 doses per vial. The third dose uses the final 1mg, leaving you needing a second vial to complete that week's 2mg administration. Two vials provide five full 2mg doses across 2.5 weeks, meaning you'll purchase eight vials across a four-week month. $336 monthly for a compound the per-mg math suggested would cost $134 monthly (2mg × 4 weeks × $16.80/mg).

Per-administration cost reveals hidden inefficiencies in protocol design. If dose flexibility exists, adjust your target dose to match vial geometry. Using 2.5mg doses instead of 2mg from a 5mg vial cuts per-administration cost from $33.60 (buying two vials to complete three 2mg doses) to $21 (one vial per two 2.5mg doses). That 37% cost reduction comes from eliminating reconstitution waste, not from cheaper peptide sources. Our experience shows that researchers who optimize dose-to-vial ratios reduce monthly spend by 20–40% without changing compounds or sacrificing therapeutic targets.

Whether you're running tissue repair protocols with P21 or metabolic studies with Lipo C, accurate cost projection starts with dose-per-vial calculations and ends with reconstitution supply inventories. Not with per-mg pricing pulled from a generic calculator. Budget the full stack before committing to multi-month protocols.